As of 2025-12-19, the Relative Valuation of Innocan Pharma Corp (INNO.CN) is 1.50 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 7.50 CAD, the upside of Innocan Pharma Corp based on Relative Valuation is -80.0%.
The range of the Relative Valuation is (0.04) - 3.94 CAD.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 2.0x | 0.1x |
| Forward P/E multiples | 7.6x - 12.3x | 9.5x |
| Fair Price | (0.04) - 3.94 | 1.50 |
| Upside | -100.5% - -47.4% | -80.0% |
| Date | P/E |
| 2025-12-11 | -20.55 |
| 2025-12-05 | -22.39 |
| 2025-12-04 | -21.13 |
| 2025-12-03 | -20.48 |
| 2025-12-02 | -20.75 |
| 2025-12-01 | -20.71 |
| 2025-11-26 | -24.88 |
| 2025-11-25 | -26.12 |
| 2025-11-24 | -26.52 |
| 2025-11-19 | -31.91 |
| 2025-11-17 | -32.55 |
| 2025-11-14 | -34.21 |
| 2025-11-11 | -33.17 |
| 2025-11-10 | -34.73 |
| 2025-11-07 | -35.25 |
| 2025-11-06 | -36.32 |
| 2025-11-05 | -37.32 |
| 2025-11-04 | -37.32 |
| 2025-11-03 | -37.32 |
| 2025-10-31 | -38.36 |
| 2025-10-30 | -37.42 |
| 2025-10-29 | -37.42 |
| 2025-10-28 | -35.25 |
| 2025-10-23 | -34.98 |
| 2025-10-22 | -33.17 |
| 2025-10-20 | -34.08 |
| 2025-10-17 | -35.00 |
| 2025-10-16 | -36.43 |
| 2025-10-15 | -33.17 |
| 2025-10-14 | -33.17 |
| 2025-10-10 | -39.60 |
| 2025-10-09 | -40.04 |
| 2025-10-08 | -40.82 |
| 2025-10-07 | -40.43 |
| 2025-10-06 | -41.47 |
| 2025-10-03 | -35.76 |
| 2025-10-02 | -35.87 |
| 2025-10-01 | -37.34 |
| 2025-09-30 | -33.59 |
| 2025-09-29 | -40.33 |
| 2025-09-26 | -30.06 |
| 2025-09-25 | -29.01 |
| 2025-09-24 | -27.78 |
| 2025-09-23 | -27.43 |
| 2025-09-22 | -25.46 |
| 2025-09-19 | -23.32 |
| 2025-09-18 | -22.81 |
| 2025-09-17 | -20.94 |